Fetzima Related Published Studies
Well-designed clinical trials related to Fetzima (Levomilnacipran)
Efficacy of levomilnacipran extended-release in improving functional impairment
associated with major depressive disorder: pooled analyses of five double-blind,
placebo-controlled trials. [2014]
Well-designed clinical trials possibly related to Fetzima (Levomilnacipran)
Resting state connectivity correlates with drug and placebo response in
fibromyalgia patients. [2014]
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia
patients: a randomized, double-blind, placebo-controlled trial. [2013]
The dubious effect of milnacipran for the treatment of burning mouth syndrome. [2011]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Milnacipran: beyond a role of antidepressant. [2009]
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter,
randomized, double-blind, placebo-controlled, multiple-dose clinical trial. [2008]
Resolution of sexual dysfunction during acute treatment of major depression with
milnacipran. [2008]
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms
of action more effective than the selective serotonin reuptake inhibitors in
treating major depressive disorder? A meta-analysis of studies of newer agents. [2007]
A meta-analysis of clinical trials comparing milnacipran, a
serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake
inhibitor for the treatment of major depressive disorder. [2007]
Efficacy of milnacipran in patients with fibromyalgia. [2005]
A double-blind placebo-controlled trial of milnacipran in the treatment of
fibromyalgia. [2004]
Milnacipran and pindolol: a randomized trial of reduction of antidepressant
latency. [2003]
Effect of pindolol and milnacipran versus milnacipran and placebo on plasma
prolactin and adrenocorticotrophic hormone in depressed subjects. [2003]
A double-blind six months comparative study of milnacipran and clomipramine in
major depressive disorder. [1997]
Other possibly related research studies
Does adding noradrenaline reuptake inhibition to selective serotonin reuptake
inhibition improve efficacy in patients with depression? A systematic review of
meta-analyses and large randomised pragmatic trials. [2013]
Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a
feasibility randomized-controlled trial. [2013]
Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic
review of pharmacokinetics, efficacy and safety with recommendations by European
Renal Best Practice (ERBP). [2012]
Desvenlafaxine in the treatment of major depressive disorder. [2011]
Prevention of poststroke depression with milnacipran in patients with acute
ischemic stroke: a double-blind randomized placebo-controlled trial. [2011]
[Possibility of a pharmacogenetic approach for prediction and personalized
medication in major depressive disorder treatment]. [Article in Japanese] [2010]
Contributions of change in clinical status parameters to Patient Global
Impression of Change (PGIC) scores among persons with fibromyalgia treated with
milnacipran. [2010]
Pharmacological treatment of fibromyalgia syndrome: new developments. [2010]
Durability of therapeutic response to milnacipran treatment for fibromyalgia.
Results of a randomized, double-blind, monotherapy 6-month extension study. [2010]
Effects of antidepressants on plasma metabolites of nitric oxide in major
depressive disorder: comparison between milnacipran and paroxetine. [2009]
Milnacipran versus other antidepressive agents for depression. [2009]
Comparative efficacy and acceptability of 12 new-generation antidepressants: a
multiple-treatments meta-analysis. [2009]
The efficacy and safety of milnacipran for treatment of fibromyalgia. a
randomized, double-blind, placebo-controlled trial. [2009]
Pragmatic consideration of recent randomized, placebo-controlled clinical trials
for treatment of fibromyalgia. [2008]
Effects of milnacipran and paroxetine on overactive bladder due to neurologic
diseases: a urodynamic assessment. [2008]
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant
responses to milnacipran. [2008]
Are SNRIs more effective than SSRIs? A review of the current state of the
controversy. [2008]
Efficacy and tolerability of milnacipran in the treatment of major depression in
comparison with other antidepressants : a systematic review and meta-analysis. [2008]
[Pharmacological treatment of fibromyalgia]. [Article in Italian] [2007]
Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor
in depressed patients. [2007]
Fibromyalgia treatment update. [2007]
Characterization and consequences of pain variability in individuals with
fibromyalgia. [2005]
Comparison of efficacy and safety of milnacipran and fluoxetine in Korean
patients with major depression. [2005]
Controlled comparison of two different doses of milnacipran in major depressive
outpatients. [2004]
Which bioequivalence study for a racemic drug? Application to milnacipran. [1998]
|
